Search results for Vedolizumab

Vedolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade, ProteoGenix, PX-TA1212

Description of Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade General information on Anti-ITGA4_ITGB7(Homo sapiens) (Vedolizumab) Monoclonal Antibody Vedolizumab is a recombinant humanized monoclonal antibody of isotype IgG1 raised against human lymphocyte alpha 4 beta 7 integrin, a key mediator of gastrointestinal inflammation. It is used for the treatment of active ulcerative colitis and Crohn’s disease. Vedolizumab can reduce intestinal inflammation by blocking its main target alpha 4 beta 7 integrin.

Vedolizumab, Affinityimmuno, ab-131-vedolizumab

Vedolizumab, Abbexa, abx831171

Vedolizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGA4/ITGB7, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.

Human Anti-Vedolizumab Antibody (Anti-Vedolizumab) ELISA Kit, Abbexa, abx392514

Human Anti-Vedolizumab Antibody (Anti-Vedolizumab) ELISA Kit is an ELISA Kit against Anti-Vedolizumab Antibody (Anti-Vedolizumab).

Vedolizumab Biosimilar - Research Grade, ichor.bio, ICH4035

Detects human Integrin alpha 4 + beta 7. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Vedolizumab.

Research Grade Vedolizumab (HY596026), abinScience, HY596026